The sales revenue of the four major pharmacies in the first half of the year all exceeded 7 billion yuan, and the growth rate of net profit slowed down

[Pharmaceutical Network Industry News] Recently, the four listed chain pharmacies, Common People, Yifeng Pharmacy, Dashenlin and Yixintang, have successively disclosed their 2022 interim reports
.

From the perspective of revenue, the sales revenue of the four pharmacies in the first half of this year has exceeded 7 billion yuan
.

The growth rate of net profit of ordinary people has slowed down, and the total number of pharmacies has exceeded 10,000.
On the evening of August 29, ordinary people released the 2022 semi-annual report showing that in the first half of the year, the company achieved operating income of 8.
991 billion yuan, a year-on-year increase of 20.
51%; net profit of 457 million yuan, A year-on-year increase of 12.
48%
.

Analysts pointed out that although the common people's housing achieved double growth in revenue and net profit in the first half of the year, the growth rate of net profit in the first half of this year slowed down significantly
.

The data shows that in the 2019 interim report to the 2022 interim report, the growth rate of its net profit attributable to the parent company was 22.
08%, 24.
39%, 20.
79% and 12.
48%, respectively, and the net profit attributable to the parent was 270 million yuan, 336 million yuan, 406 million yuan and 457 million yuan
.

It is reported that in the first half of the year, the store expansion of ordinary people accelerated, and the total number of pharmacies has exceeded 10,000
.

The common people said that while the scale of stores is expanding rapidly, the company has further clarified the expansion strategy, focusing on 16 provinces, that is, the "9+7" expansion strategy
.

Among them, the strategies of 9 provinces are self-construction, Spark (M&A), franchise, and alliance.
The strategy of 7 provinces is to focus on the expansion of franchise and alliance with light assets, and the existing stores are used to improve online sales such as O2O
.
Yifeng Pharmacy’s growth rate was also relatively weak, with net profit increasing by 14.
2%.
According to the 2022 semi-annual report recently released by Yifeng Pharmacy, the company achieved operating income of 8.
75 billion yuan in the first half of the year, a year-on-year increase of 19.
11%; net profit attributable to shareholders of listed companies The profit was 576 million yuan, a year-on-year increase of 14.
2%; the net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 559 million yuan, a year-on-year increase of 13.
31%
.

Analysts pointed out that in the first half of this year, Yifeng Pharmacy's net profit growth was relatively weak
.

Among them, the data shows that from the 2019 interim report to the 2022 interim report, Yifeng Pharmacy's net profit growth rate attributable to the parent company was 36.
78%, 33.
84%, 25.
66% and 14.
20%, respectively, and the net profit attributable to the parent was 308 million yuan.
, 412 million yuan, 505 million yuan and 576 million yuan
.

 　　The announcement shows that the main reason for the company's revenue growth in the first half of this year is the endogenous growth of old stores compared to the same period last year; new stores, mergers and acquisitions in the same industry, and franchised distribution businesses continue to expand
.

It is reported that in the first half of the year, the company has a net increase of 1,391 stores
.

Among them, 546 stores were newly opened, 363 stores were acquired, 584 stores were newly added, and 102 stores were closed.
At the end of the period, the total number of stores was 9,200 (including 1,516 franchise stores)
.

The company's net profit growth in the first half of the year mainly came from the endogenous growth of old stores, the extensional growth of M&A stores and the improvement of the company's management efficiency
.

 　　The growth rate of Dashenlin's net profit exceeded that of the previous year's interim report, but it was not as good as the previous Dashenlin's 2022 semi-annual performance report.
The company achieved operating income of 9.
721 billion yuan in the first half of the year, a year-on-year increase of 20.
68%; net profit attributable to the parent was 714 million yuan.
A year-on-year increase of 10.
62%
.

 　　The report shows that in the first half of the year, Dashenlin achieved a 10% increase in sales in South China, a 22.
46% increase in Central China, a 53.
23% increase in East China, and a 196.
79% increase in Northeast, North, Northwest and Southwest markets.
During the year, the company added a total of 703 stores
.

 　　In addition, in the first half of the year, the Dashenlin pharmacy chain has covered 8,896 pharmacies in 15 provinces (including municipalities and autonomous regions) across the country, including 1,376 franchise stores
.

Added 194 self-built stores, 441 franchised stores, and 172 acquired stores
.

 The company's O2O drug delivery service has covered 7,639 stores across the country, with an online rate of 85.
17%.
The sales of new retail business (O2O+B2C) increased by 63.
95% year-on-year
.

 　　Analysts pointed out that in the first half of 2022, the growth rate of Dashenlin's net profit exceeded the 2021 mid-year report, but not as fast as before
.

Among them, from the 2019 interim report to the 2022 interim report, the growth rate of Dashenlin's net profit attributable to the parent company was 32.
21%, 56.
21%, 8.
56% and 10.
62%, respectively, and the net profit attributable to the parent was 381 million yuan and 595 million yuan respectively.
, 646 million yuan and 714 million yuan
.

 　　Yixintang "increases revenue without increasing profits", with a net profit growth rate of -20.
16% Yixintang's performance report for the first half of 2022 shows that the company achieved revenue of 7.
965 billion yuan, an increase of 18.
85% year-on-year; net profit attributable to shareholders of listed companies was 418 million yuan , a year-on-year decrease of 20.
16%
.

 　　According to the report, Yixintang opened 578 new stores and closed 61 stores in the first half of this year
.

Compared with the 2021 interim report, 950 new stores were opened and 17 stores were closed.
The expansion of Yixintang stores slowed down in the first half of this year
.

 　　Yixintang mentioned in the interim report that it is necessary to reduce operating costs and continue to promote the development idea of ​​reducing rent and increasing efficiency
.

It said that through the budget control of daily expenses in the front and back offices, the comprehensive and reduction of operating costs can be achieved
.

With the continuous expansion of the store scale, we will continuously optimize and control various operating expenses and costs of the store, and improve the profit margin of the store
.

Strengthen the level of back-office management, optimize human efficiency and creativity, and increase per capita output value
.

 　　It is understood that from 2019 to 2021, Yixintang's revenue and net profit have grown for three consecutive years, with revenue increasing by 14.
20%, 20.
78%, and 15.
26%, respectively, to 10.
48 billion yuan, 12.
66 billion yuan, and 14.
59 billion yuan; net profit increased respectively.
15.
90%, 30.
81%, 16.
66%, 604 million yuan, 790 million yuan, and 922 million yuan
.

 　　Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.